SELLAS Life Sciences Group's total assets for Q3 2025 were $51.55M, an increase of 59.59% from the previous quarter. SLS total liabilities were $5.92M for the fiscal quarter, a -3.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.